Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America

Lindsay E. Nicolle, Kalpana Gupta, Suzanne F. Bradley, Richard Colgan, Gregory P. DeMuri, Dimitri Drekonja, Linda O. Eckert, Suzanne E. Geerlings, B. la Köves, Thomas M. Hooton, Manisha Juthani-Mehta, Shandra L. Knight, Sanjay Saint, Anthony J. Schaeffer, Barbara Trautner, Bjorn Wullt, Reed Siemieniuk

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be screened for and treated only in pregnant women or in an individual prior to undergoing invasive urologic procedures. Treatment was not recommended for healthy women; older women or men; or persons with diabetes, indwelling catheters, or spinal cord injury. The guideline did not address children and some adult populations, including patients with neutropenia, solid organ transplants, and nonurologic surgery. In the years since the publication of the guideline, further information relevant to ASB has become available. In addition, antimicrobial treatment of ASB has been recognized as an important contributor to inappropriate antimicrobial use, which promotes emergence of antimicrobial resistance. The current guideline updates the recommendations of the 2005 guideline, includes new recommendations for populations not previously addressed, and, where relevant, addresses the interpretation of nonlocalizing clinical symptoms in populations with a high prevalence of ASB.
Original languageEnglish
Pages (from-to)1611-1615
Number of pages5
JournalClinical Infectious Diseases
Volume68
Issue number10
DOIs
Publication statusPublished - 1 May 2019
Externally publishedYes

Cite this

Nicolle, L. E., Gupta, K., Bradley, S. F., Colgan, R., DeMuri, G. P., Drekonja, D., ... Siemieniuk, R. (2019). Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 68(10), 1611-1615. https://doi.org/10.1093/cid/ciz021
Nicolle, Lindsay E. ; Gupta, Kalpana ; Bradley, Suzanne F. ; Colgan, Richard ; DeMuri, Gregory P. ; Drekonja, Dimitri ; Eckert, Linda O. ; Geerlings, Suzanne E. ; Köves, B. la ; Hooton, Thomas M. ; Juthani-Mehta, Manisha ; Knight, Shandra L. ; Saint, Sanjay ; Schaeffer, Anthony J. ; Trautner, Barbara ; Wullt, Bjorn ; Siemieniuk, Reed. / Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. In: Clinical Infectious Diseases. 2019 ; Vol. 68, No. 10. pp. 1611-1615.
@article{595f811380524e86af7beec0e2d4c292,
title = "Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America",
abstract = "Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be screened for and treated only in pregnant women or in an individual prior to undergoing invasive urologic procedures. Treatment was not recommended for healthy women; older women or men; or persons with diabetes, indwelling catheters, or spinal cord injury. The guideline did not address children and some adult populations, including patients with neutropenia, solid organ transplants, and nonurologic surgery. In the years since the publication of the guideline, further information relevant to ASB has become available. In addition, antimicrobial treatment of ASB has been recognized as an important contributor to inappropriate antimicrobial use, which promotes emergence of antimicrobial resistance. The current guideline updates the recommendations of the 2005 guideline, includes new recommendations for populations not previously addressed, and, where relevant, addresses the interpretation of nonlocalizing clinical symptoms in populations with a high prevalence of ASB.",
keywords = "Asymptomatic bacteriuria, Bacteriuria, Cystitis, Diabetes, Endourologic surgery, Long-term care, Neurogenic bladder, Nursing home, Older adults, Pregnancy, Pyelonephritis, Renal transplant, Spinal cord injury, Urinary catheter, Urinary tract infection, Urologic devices",
author = "Nicolle, {Lindsay E.} and Kalpana Gupta and Bradley, {Suzanne F.} and Richard Colgan and DeMuri, {Gregory P.} and Dimitri Drekonja and Eckert, {Linda O.} and Geerlings, {Suzanne E.} and K{\"o}ves, {B. la} and Hooton, {Thomas M.} and Manisha Juthani-Mehta and Knight, {Shandra L.} and Sanjay Saint and Schaeffer, {Anthony J.} and Barbara Trautner and Bjorn Wullt and Reed Siemieniuk",
year = "2019",
month = "5",
day = "1",
doi = "10.1093/cid/ciz021",
language = "English",
volume = "68",
pages = "1611--1615",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "10",

}

Nicolle, LE, Gupta, K, Bradley, SF, Colgan, R, DeMuri, GP, Drekonja, D, Eckert, LO, Geerlings, SE, Köves, BL, Hooton, TM, Juthani-Mehta, M, Knight, SL, Saint, S, Schaeffer, AJ, Trautner, B, Wullt, B & Siemieniuk, R 2019, 'Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America' Clinical Infectious Diseases, vol. 68, no. 10, pp. 1611-1615. https://doi.org/10.1093/cid/ciz021

Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. / Nicolle, Lindsay E.; Gupta, Kalpana; Bradley, Suzanne F.; Colgan, Richard; DeMuri, Gregory P.; Drekonja, Dimitri; Eckert, Linda O.; Geerlings, Suzanne E.; Köves, B. la; Hooton, Thomas M.; Juthani-Mehta, Manisha; Knight, Shandra L.; Saint, Sanjay; Schaeffer, Anthony J.; Trautner, Barbara; Wullt, Bjorn; Siemieniuk, Reed.

In: Clinical Infectious Diseases, Vol. 68, No. 10, 01.05.2019, p. 1611-1615.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America

AU - Nicolle, Lindsay E.

AU - Gupta, Kalpana

AU - Bradley, Suzanne F.

AU - Colgan, Richard

AU - DeMuri, Gregory P.

AU - Drekonja, Dimitri

AU - Eckert, Linda O.

AU - Geerlings, Suzanne E.

AU - Köves, B. la

AU - Hooton, Thomas M.

AU - Juthani-Mehta, Manisha

AU - Knight, Shandra L.

AU - Saint, Sanjay

AU - Schaeffer, Anthony J.

AU - Trautner, Barbara

AU - Wullt, Bjorn

AU - Siemieniuk, Reed

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be screened for and treated only in pregnant women or in an individual prior to undergoing invasive urologic procedures. Treatment was not recommended for healthy women; older women or men; or persons with diabetes, indwelling catheters, or spinal cord injury. The guideline did not address children and some adult populations, including patients with neutropenia, solid organ transplants, and nonurologic surgery. In the years since the publication of the guideline, further information relevant to ASB has become available. In addition, antimicrobial treatment of ASB has been recognized as an important contributor to inappropriate antimicrobial use, which promotes emergence of antimicrobial resistance. The current guideline updates the recommendations of the 2005 guideline, includes new recommendations for populations not previously addressed, and, where relevant, addresses the interpretation of nonlocalizing clinical symptoms in populations with a high prevalence of ASB.

AB - Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be screened for and treated only in pregnant women or in an individual prior to undergoing invasive urologic procedures. Treatment was not recommended for healthy women; older women or men; or persons with diabetes, indwelling catheters, or spinal cord injury. The guideline did not address children and some adult populations, including patients with neutropenia, solid organ transplants, and nonurologic surgery. In the years since the publication of the guideline, further information relevant to ASB has become available. In addition, antimicrobial treatment of ASB has been recognized as an important contributor to inappropriate antimicrobial use, which promotes emergence of antimicrobial resistance. The current guideline updates the recommendations of the 2005 guideline, includes new recommendations for populations not previously addressed, and, where relevant, addresses the interpretation of nonlocalizing clinical symptoms in populations with a high prevalence of ASB.

KW - Asymptomatic bacteriuria

KW - Bacteriuria

KW - Cystitis

KW - Diabetes

KW - Endourologic surgery

KW - Long-term care

KW - Neurogenic bladder

KW - Nursing home

KW - Older adults

KW - Pregnancy

KW - Pyelonephritis

KW - Renal transplant

KW - Spinal cord injury

KW - Urinary catheter

KW - Urinary tract infection

KW - Urologic devices

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066159305&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31506700

U2 - 10.1093/cid/ciz021

DO - 10.1093/cid/ciz021

M3 - Review article

VL - 68

SP - 1611

EP - 1615

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 10

ER -